Cargando…
Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel–Mediated Cardiotoxicity
Psilocybin, a hallucinogen contained in “magic” mushrooms, holds great promise for the treatment of various psychiatric disorders, and early clinical trials are encouraging. Adverse cardiac events after intake of high doses of psilocybin and a trial reporting QT interval prolongation in the electroc...
Autores principales: | Hackl, Benjamin, Todt, Hannes, Kubista, Helmut, Hilber, Karlheinz, Koenig, Xaver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017764/ https://www.ncbi.nlm.nih.gov/pubmed/34871422 http://dx.doi.org/10.1093/ijnp/pyab085 |
Ejemplares similares
-
Decreased inward rectifier potassium current I(K1) in dystrophin-deficient ventricular cardiomyocytes
por: Rubi, Lena, et al.
Publicado: (2016) -
Calcium current properties in dystrophin‐deficient ventricular cardiomyocytes from aged mdx mice
por: Rubi, Lena, et al.
Publicado: (2018) -
Evidence for a Physiological Role of T-Type Ca Channels in Ventricular Cardiomyocytes of Adult Mice
por: Marksteiner, Jessica, et al.
Publicado: (2022) -
Na(+) Permeation and Block of hERG Potassium Channels
por: Gang, Hongying, et al.
Publicado: (2006) -
Stereoselective Inhibition of the hERG1 Potassium Channel
por: Grilo, Liliana Sintra, et al.
Publicado: (2010)